PR
Paul M. Ridker is a clinical researcher at Harvard University. His work centers on cardiovascular medicine and the role of inflammation in atherosclerosis, including the use of biomarkers such as C-reactive protein to assess cardiovascular risk. He has contributed to clinical trials that evaluate anti-inflammatory and lipid-lowering therapies for preventing cardiovascular events.
- Field
- Medicine · Cardiology
- Clarivate categories
- Clinical Medicine
- Affiliation
- Harvard University, United States
- Secondary affiliation
- Brigham & Women's Hospital, United States